CUSCADEN PEAK PTE. LTD.
(Incorporated in the Republic of Singapore)
(Company Registration No.: 202135018H)
PROPOSED ACQUISITION BY CUSCADEN PEAK PTE. LTD. OF ALL THE ISSUED ORDINARY
SHARES IN THE CAPITAL OF SINGAPORE PRESS HOLDINGS LIMITED
BY WAY OF A SCHEME OF ARRANGEMENT
UPDATE ANNOUNCEMENT - (1) RECEIPT OF FIRB APPROVAL AS FINAL REGULATORY APPROVAL TO BE OBTAINED BY CUSCADEN AND (2) WAIVER OF SCHEME CONDITION IN RELATION TO NO MATERIAL ADVERSE EFFECT
1. INTRODUCTION
The Board of Directors of Cuscaden Peak Pte. Ltd. (the "Offeror" or "Cuscaden") refers to inter alia:
- the joint announcement (the "Cuscaden Joint Announcement") by the Offeror and Singapore Press Holdings Limited (the "Company") to the shareholders of the Company (the "Shareholders") on 15 November 2021 in relation to the proposed acquisition by the Offeror of all the issued and paid-up ordinary shares (the "Shares") in the capital of the Company by way of a scheme of arrangement ("Cuscaden Scheme") under Section 210 of the Companies Act, Chapter 50 of Singapore (the "Companies Act") and the Singapore Code on Take-overs and Mergers (the "Code"); and
- the update announcement ("Update Announcement") and media release by Cuscaden to the Shareholders on 21 November 2021 in relation to certain updates in respect of the Regulatory Approvals obtained by Cuscaden from the Monetary Authority of Singapore and the Info-Communications Media Development Authority.
Unless otherwise defined, capitalised terms in this Announcement shall bear the same meaning as set out in the Cuscaden Joint Announcement
2. FIRB APPROVAL AS FINAL REGULATORY APPROVAL TO BE OBTAINED BY CUSCADEN
As mentioned in the Cuscaden Joint Announcement, the Cuscaden Scheme is conditional upon the satisfaction and/or waiver (as the case may be) of certain conditions set out in the Cuscaden Implementation Agreement ("Scheme Conditions"), which have been reproduced in the Schedule to this Announcement. The updated status of each Scheme Condition as at the date of this Announcement is also set out in the Schedule to this Announcement.
In particular, Cuscaden would like to update Shareholders that since the Update Announcement, it has received the final outstanding Regulatory Approval to be obtained by Cuscadenunder the Scheme Conditions, being that of clearance from the Foreign Investment Review Board under the Australian Foreign Acquisitions and Takeovers Act 1975 (the "FIRB Approval Condition").
1
Accordingly, all Regulatory Approvals to be obtained by Cuscaden under the Scheme Conditions have been received1.
-
WAIVER OF SCHEME CONDITION IN RELATION TO NO MATERIAL ADVERSE EFFECT
Cuscaden has also entered into a supplemental letter with the Company to unconditionally and irrevocably waive the Scheme Condition reproduced in paragraph 11 of the Schedule to this Announcement in relation to there having been no occurrence of any Material Adverse Effect from the date of the Cuscaden Implementation Agreement up to the Relevant Date (both inclusive) ("No Material Adverse Effect Condition").
The waiver by Cuscaden of the No Material Adverse Effect Condition shall not operate or be construed as a waiver of a breach or non-fulfilment of any other Scheme Condition.
With the fulfilment of the FIRB Approval Condition and the waiver of the No Material Adverse Effect Condition, Cuscaden has exhibited its strong commitment to and track record in providing transaction certainty with respect to the Cuscaden Scheme for the benefit of the Shareholders. It is also committed to achieving successful completion of the Cuscaden Scheme expeditiously. Accordingly, Cuscaden will continue to work closely with the Company for the despatch of the Composite Document and convening of the Cuscaden Scheme Meeting as soon as possible, in the interests of Shareholders. - RESPONSIBILITY STATEMENT
The directors of the Offeror (including any who may have delegated detailed supervision of the preparation of this Announcement) have taken all reasonable care to ensure that the facts stated and all opinions expressed in this Announcement (excluding information relating to the Company, SPH REIT or the Keppel Scheme or any opinion expressed by the Company, the Keppel Offeror or the IFA) are fair and accurate and that, where appropriate, no material facts which relate to the Offeror have been omitted from this Announcement the omission of which would make any statement in this Announcement misleading. The directors of the Offeror jointly and severally accept responsibility accordingly.
Where any information has been extracted or reproduced from published or otherwise publicly available sources or obtained from a named source, the sole responsibility of the directors of the Offeror has been to ensure that, through reasonable enquiries, such information is accurately extracted from such sources or, as the case may be, reflected or reproduced in this Announcement. The directors of the Offeror do not accept any responsibility for any information relating to the Company, SPH REIT or the Keppel Scheme or any opinion or rationale expressed by the Company, the Keppel Offeror or the IFA.
1 The remaining Regulatory Approval to be obtained is in respect of the approval-in-principle from the SGX-ST of the Composite Document and for the proposed delisting of the Company from the SGX-ST, which is to be obtained by the Company.
2
By order of the board of directors
CUSCADEN PEAK PTE. LTD.
2 December 2021
Any queries relating to this Announcement should be directed to one of the following:
Morgan Stanley Asia (Singapore) Pte.
as Financial Adviser to Cuscaden Peak Pte. Ltd. Tel: +65 6834 6857
For media enquiries, please contact:
Klareco Communications Pte. Ltd.
Ms Ang Shih-Huei / Ms Pearl Lam
Tel No: +65 9189 1039 / +65 9724 0521
Email:SAng@klarecocomms.com/plam@klarecocomms.com
Forward-Looking Statements
All statements other than statements of historical facts included in this Announcement are or may be forward-looking statements. Forward-looking statements include but are not limited to those using words such as "seek", "expect", "anticipate", "estimate", "believe", "intend", "project", "plan", "strategy", "forecast" and similar expressions or future or conditional verbs such as "will", "would", "should", "could", "may" and "might". These statements reflect the Offeror's or the Company's (as the case may be) current expectations, beliefs, hopes, intentions or strategies regarding the future and assumptions in light of currently available information. Such forward-looking statements are not guarantees of future performance or events and involve known and unknown risks and uncertainties. Accordingly, actual results may differ materially from those described in such forward-looking statements. Shareholders and investors of the Offeror and the Company should not place undue reliance on such forward-looking statements, and neither the Offeror nor the Company undertakes any obligation to update publicly or revise any forward-looking statements.
3
SCHEDULE
Scheme Conditions
All capitalised terms used and not defined in this Announcement shall have the same meanings given to them in the Cuscaden Implementation Agreement, a copy of which is available for inspection during normal business hours at the registered office of the Company from the Cuscaden Joint Announcement Date up until the Effective Date. All references to Clauses and Schedules below refer to the clauses and schedules of the Cuscaden Implementation Agreement.
Pursuant to Clause 3.1 of the Cuscaden Implementation Agreement, the Acquisition and the Cuscaden Scheme are conditional upon the satisfaction (or, where applicable, the waiver) of the following conditions precedent to the implementation of the Cuscaden Scheme:
No. | Scheme Condition | Status | ||
1. | Approval by Shareholders for the Cuscaden Scheme: the | To be sought at the Cuscaden | ||
approval of the Cuscaden Scheme by a majority in number | Scheme Meeting to be convened | |||
representing three-fourths in value of the Shareholders present | by the Company | |||
and voting at the Cuscaden Scheme Meeting pursuant to the | ||||
requirements of Section 210(3AB) of the Companies Act; | ||||
2. | Approval by Shareholders for the DIS: the approval by the | To be sought at the EGM to be | ||
Shareholders at the EGM for a distribution-in-specie by the | convened by the Company | |||
Company of the Relevant SPH REIT Units to each Eligible | ||||
Shareholder as part of the Cuscaden Scheme Consideration; | ||||
3. | Completion of the Media Business Restructuring: the | Completed on 1 December 2021 | ||
completion of the Media Business Restructuring (including the | ||||
Conversion on or prior to the Record Date) on or prior to the | ||||
Record Date; | ||||
4. | Court Order: the grant of the Scheme Court Order by the Court | To be sought after the Cuscaden | ||
and such court order having become final; | Scheme Meeting | |||
5. | ACRA Lodgement: the lodgement of the Scheme Court Order | The Scheme Court Order is | ||
with ACRA in accordance with Section 210(5) of the Companies | targeted to be lodged with ACRA | |||
Act; | on or around the date falling 10 | |||
Business Days after the close of | ||||
the election period | ||||
6. | Regulatory Approvals: (a) all the Regulatory Approvals having | See status as set out in (i) to (v) of | ||
been obtained or granted and remaining in full force and effect | this Schedule below | |||
from the date such Regulatory Approvals are obtained or granted, | ||||
up to the Relevant Date, and (b) where relevant, all applicable | ||||
waiting periods in relation to the Regulatory Approvals having | ||||
expired or been terminated; | ||||
(i) | confirmation from the SIC that: | Satisfied | ||
(a) | Rules 14, 15, 16, 17, 20.1, 21, 22, 28, 29 and 33.2 | |||
and Note 1(b) on Rule 19 of the Code do not apply | ||||
to the Cuscaden Scheme; and | ||||
(b) | the SIC has no objections to the Cuscaden | |||
Scheme Conditions; | ||||
4 |
No. | Scheme Condition | Status | |
(ii) | approval-in-principle from the SGX-ST of the Composite | Pending | |
Document and for the proposed delisting of the Company | |||
from the SGX-ST after the Cuscaden Scheme becomes | |||
effective and binding in accordance with its terms; | |||
(iii) | approval, pursuant to Section 32B of the | Satisfied | |
Telecommunications Act, Chapter 323 of Singapore, from | |||
the Info-Communications Media Development Authority in | |||
connection with the acquisition by the Offeror of an indirect | |||
interest in M1 Limited pursuant to the acquisition of voting | |||
shares or voting power of the Company arising from the | |||
Cuscaden Scheme becoming effective in accordance with | |||
its terms; | |||
(iv) | approval from the Monetary Authority of Singapore | Satisfied | |
necessary for a change in control of the SPH REIT | |||
Manager and the acquisition of effective control of KBS US | |||
Prime Property Management Pte. Ltd. arising from the | |||
Cuscaden Scheme; and | |||
(v) | clearance from the Foreign Investment Review Board | Satisfied | |
under the Australian Foreign Acquisitions and Takeovers | |||
Act 1975; | |||
7. | No Illegality: between the date of the Cuscaden Implementation | To be determined on the Relevant | |
Agreement and up to the Relevant Date, no order, injunction, | Date | ||
judgment or decree issued by any Governmental Authority or other | |||
legal restraints or prohibition preventing the consummation of the | |||
Acquisition or implementation of the Cuscaden Scheme shall be in | |||
effect; | |||
8. | No Prescribed Occurrence: between the date of the Cuscaden | To be determined on the Relevant | |
Implementation Agreement and up to the Relevant Date, no | Date | ||
Prescribed Occurrence in relation to (a) the Offeror; or (b) any SPH | |||
Group Company or Woodleigh JV, in each case, occurring other | |||
than as required or contemplated by the Cuscaden Implementation | |||
Agreement or the Cuscaden Scheme; | |||
9. | Company Warranties: there having been no material breach by the | To be determined on the Relevant | |
Company of its warranties given under the Cuscaden | Date | ||
Implementation Agreement as at the date of the Cuscaden | |||
Implementation Agreement and as at the Relevant Date as though | |||
made on and as at each such date, except to the extent any warranty | |||
given by it expressly relates to an earlier date (in which case as at | |||
such earlier date), in each such case, which has resulted in a | |||
Material Adverse Effect and not been substantially remedied as of | |||
the Relevant Date and is material in the context of the Cuscaden | |||
Scheme; | |||
10. | Offeror Warranties: there having been no material breach by the | To be determined on the Relevant | |
Offeror of its warranties given under the Cuscaden Implementation | Date | ||
Agreement as at the date of the Cuscaden Implementation | |||
Agreement and as at the Relevant Date as though made on and | |||
as at each such date, except to the extent any warranty given by it | |||
5 |
This is an excerpt of the original content. To continue reading it, access the original document here.
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
SPH REIT published this content on 02 December 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 02 December 2021 15:00:04 UTC.